Hrt Financial LP Oric Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.26 - $6.75 $537,386 - $851,492	126,147 New	126,147 $719,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.07 $125,404 - $328,373	-46,446 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.54 - $16.1 $210,864 - $747,780	46,446 New	46,446 $248,000
Q2 2021 Aug 16, 2021	SELL	$17.37 - $25.34 $860,058 - $1.25 Million	-49,514 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$23.67 - $36.85 $1.17 Million - $1.82 Million	49,514 New	49,514 $1.21 Million

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.